The trajectory of Sildenafil presents a challenging picture for investors. While the initial launch generated massive profits, the end of its exclusive rights opened the avenue to generic competitors, dramatically https://ilovebookmarking.com/story21637961/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet